On November 4, 2021, the Japan-based AIDE Project team met with our six-member Advisory Board. We presented our work to date with our Patient and Public Involvement Panels (PPIPs) in Japan and the UK, and our work on the Twitter study and scoping review. We also introduced our plans for our focus group research and received advice, suggestions, and questions from the Board to help us to move forward and strengthen our work. Each Board member makes a unique contribution from their particular background and specialty. Together, the Advisory Boards in both countries continue to be valuable assets to our entire team. We look forward to our next meeting.
The role of the Advisory Board is different from that of the PPIPs in this project. They are less involved in the co-production of the research, but offer advice from their specialist backgrounds including law, science and technology, medicine, big data and patient involvement research and advocacy. This advice enriches the project by enabling us to look at issues around AI and healthcare from multiple perspectives.